Patents by Inventor Shuhei Ohnishi

Shuhei Ohnishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazole derivatives
    Patent number: 6387938
    Abstract: This invention provides novel benzimidazole derivatives represented by the formula (I); a process for producing the same; a drug containing at least one of such compounds as its active ingredient, in particular, a drug for preventing and/or treating diseases exhibiting eosinophilia, bronchial asthma and allergic diseases; and an enhancer for IFN-&ggr; production, and in particular, an antitumor agent or an antiviral agent based on the action of enhancing the IFN-&ggr; production which exhibits excellent oral bioavailability.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: May 14, 2002
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Kiyoshi Mizuguchi, Nobuo Ohzawa, Yasuhiro Nakai, Kazuyuki Matsuura, Shuhei Ohnishi, Yutaka Kato, Tsutomu Satoh
  • Azolyl methyl phenyl derivatives having aromatase inhibitory activity
    Patent number: 5587392
    Abstract: Compounds exerting excellent aromatase inhibitory activity in vivo and in vitro with higher specificity and greater safety are provided together with the salts thereof. Using the same, there are also provided, prophylactic agents and/or therapeutical agents of estrogen-dependent diseases, contraceptive agents for females, and aromatase inhibitory agents for use in the form of reagents for human or animals. The compounds are of the formula (I), wherein R.sup.2 is represented by the formula (II) or (III).
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: December 24, 1996
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Kimihiro Murakami, Shuhei Ohnishi, Takashi Yano, Manabu Itoh
  • Pyrimidine derivatives
    Patent number: 5397781
    Abstract: The present invention relates to novel 5-(.omega.-substituted amino-alkanoyl amino)pyrimidine derivatives, processes for producing the derivatives, and pharmaceutical compositions containing said derivatives. The compounds in the present invention have potent effects of inhibiting ACAT activity and lowering serum cholesterol. The compounds of the present invention are extremely useful for the treatment and/or prevention of arteriosclerosis or hyperlipidemia.
    Type: Grant
    Filed: February 11, 1993
    Date of Patent: March 14, 1995
    Assignee: Mochida Pharmaceutical Company, Limited
    Inventors: Kazutoshi Yanagibashi, Kiyoshi Mizuguchi, Shuhei Ohnishi, Kimihiro Murakami